CERS: Cerus Corp.
About
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Current Value
$1.841 Year Return
Current Value
$1.841 Year Return
Key Details
Market Cap
$336.14M
P/E Ratio
-16.82
1Y Stock Return
9.04%
1Y Revenue Growth
14.71%
Dividend Yield
0.00%
Price to Book
6.3
Strategies that include CERS
Stock's related to CERS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEAM | 52.87% | $2.50B | +15.98% | 0.00% |
| ADPT | 48.97% | $990.26M | +53.20% | 0.00% |
| TXG | 48.55% | $1.96B | -66.80% | 0.00% |
| EXLS | 47.25% | $7.45B | +58.85% | 0.00% |
| ABCL | 47.23% | $892.01M | -36.82% | 0.00% |
| MVIS | 46.62% | $190.44M | -63.47% | 0.00% |
| CRSP | 46.57% | $4.16B | -16.24% | 0.00% |
| LAW | 46.15% | $382.22M | -7.27% | 0.00% |
| SOFI | 45.93% | $16.59B | +92.33% | 0.00% |
| EDIT | 45.71% | $173.35M | -78.66% | 0.00% |
| FLGT | 45.54% | $618.77M | -25.16% | 0.00% |
| EXPI | 44.94% | $2.01B | -7.95% | 1.52% |
| NTLA | 44.82% | $1.50B | -47.71% | 0.00% |
| SDGR | 44.78% | $1.61B | -29.74% | 0.00% |
| NVEE | 44.19% | $1.38B | -19.25% | 0.00% |
| LPRO | 44.08% | $730.42M | -9.06% | 0.00% |
| RDFN | 43.87% | $1.17B | +21.81% | 0.00% |
| CARS | 43.81% | $1.24B | +1.54% | 0.00% |
| RXRX | 43.61% | $2.90B | +0.27% | 0.00% |
| RKT | 43.59% | $1.83B | +16.48% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| STNG | 0.06% | $2.60B | -8.02% | 3.25% |
| ALAB | 0.08% | $18.74B | +228.25% | 0.00% |
| CDRE | 0.12% | $1.42B | +8.16% | 0.99% |
| QXO | 0.12% | $6.67B | -74.26% | 0.00% |
| CNA | 0.13% | $13.08B | +20.72% | 3.65% |
| TEN | 0.20% | $548.21M | -4.72% | 4.84% |
| TKC | -0.21% | $5.81B | +39.62% | 4.37% |
| NLOP | 0.22% | $470.16M | +55.50% | 0.00% |
| MKL | -0.24% | $22.57B | +25.96% | 0.00% |
| FATBB | 0.32% | $78.36M | -13.14% | 12.28% |
| MMC | -0.34% | $105.88B | +7.18% | 1.41% |
| NHTC | 0.38% | $54.23M | -15.29% | 17.09% |
| TGS | 0.40% | $1.98B | +93.30% | 0.00% |
| CMBT | 0.43% | $1.99B | -41.30% | 16.31% |
| PRT | 0.45% | $44.77M | -18.41% | 10.98% |
| CEPU | -0.49% | $2.15B | +53.30% | 0.00% |
| GOGL | 0.51% | $1.89B | +8.25% | 12.88% |
| BACK | 0.56% | $2.07M | -23.57% | 0.00% |
| CCEC | 0.57% | $1.01B | +39.16% | 3.28% |
| NXTC | -0.59% | $31.65M | -15.67% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -18.97% | $74.13B | +26.36% | 0.46% |
| CHD | -18.25% | $26.23B | +13.34% | 1.05% |
| CAH | -15.23% | $29.14B | +11.57% | 1.66% |
| LPLA | -13.01% | $24.26B | +42.13% | 0.37% |
| CYD | -11.47% | $370.18M | +10.76% | 4.19% |
| RNR | -10.73% | $13.98B | +29.28% | 0.58% |
| PGR | -10.48% | $144.85B | +49.74% | 0.46% |
| VSTA | -10.46% | $176.78M | -47.12% | 0.00% |
| TPST | -10.07% | $38.66M | -74.17% | 0.00% |
| ACGL | -8.91% | $35.12B | +22.28% | 0.00% |
| GEV | -8.15% | $90.25B | +149.44% | 0.00% |
| MNR | -7.70% | $1.52B | -11.84% | 21.63% |
| COR | -7.25% | $45.81B | +16.21% | 0.89% |
| AJG | -6.83% | $62.25B | +14.60% | 0.84% |
| CBOE | -6.47% | $21.25B | +13.78% | 1.16% |
| UUU | -6.42% | $5.11M | +15.05% | 0.00% |
| RGA | -6.41% | $13.87B | +24.14% | 1.65% |
| HUSA | -6.15% | $16.88M | -24.12% | 0.00% |
| BTCT | -6.02% | $39.13M | +169.13% | 0.00% |
| IBKR | -5.85% | $19.16B | +110.15% | 0.48% |
ETF's related to CERS
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 61.00% | $1.23B | 0.75% |
| KOMP | 58.29% | $2.23B | 0.2% |
| PRFZ | 56.74% | $2.73B | 0.39% |
| IWC | 56.55% | $1.02B | 0.6% |
| IWM | 56.46% | $81.77B | 0.19% |
| VTWO | 56.38% | $13.00B | 0.1% |
| NUSC | 55.71% | $1.32B | 0.31% |
| ARKK | 55.58% | $6.96B | 0.75% |
| IWO | 55.44% | $13.28B | 0.24% |
| SPSM | 55.34% | $13.18B | 0.03% |
| IWN | 55.31% | $13.69B | 0.24% |
| IJR | 55.28% | $93.82B | 0.06% |
| ESML | 55.14% | $1.96B | 0.17% |
| PBW | 54.91% | $323.88M | 0.65% |
| GNOM | 54.88% | $78.98M | 0.5% |
| FYX | 54.82% | $1.01B | 0.6% |
| VXF | 54.67% | $22.73B | 0.06% |
| VBK | 54.59% | $20.66B | 0.07% |
| VIOO | 54.59% | $3.29B | 0.1% |
| IJS | 54.51% | $7.64B | 0.18% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FLTR | -0.05% | $1.86B | 0.14% |
| AGZD | 0.08% | $132.89M | 0.23% |
| MINT | 0.59% | $11.81B | 0.35% |
| TAIL | -0.62% | $68.43M | 0.59% |
| FLRN | -0.80% | $2.37B | 0.15% |
| CSHI | -0.96% | $481.04M | 0.38% |
| TBIL | -1.52% | $4.51B | 0.15% |
| JUCY | 1.57% | $324.26M | 0.6% |
| BIL | -1.76% | $34.60B | 0.1356% |
| BILZ | 1.79% | $558.25M | 0.14% |
| CLOI | 2.25% | $773.20M | 0.4% |
| DBO | 2.41% | $210.06M | 0.77% |
| THTA | 2.42% | $34.40M | 0.49% |
| DBE | 2.88% | $49.18M | 0.77% |
| HDRO | 3.28% | $164.26M | 0.3% |
| FLOT | 3.29% | $7.41B | 0.15% |
| CANE | 3.35% | $15.69M | 0.29% |
| UNG | -3.49% | $854.11M | 1.06% |
| SGOV | 3.49% | $28.68B | 0.09% |
| XBIL | 3.71% | $632.22M | 0.15% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| USDU | -27.49% | $211.42M | 0.5% |
| UUP | -24.35% | $386.70M | 0.77% |
| VIXY | -15.33% | $195.31M | 0.85% |
| CTA | -14.09% | $380.14M | 0.76% |
| MSOS | -9.47% | $541.36M | 0.83% |
| DBA | -8.91% | $793.07M | 0.93% |
| JBBB | -7.75% | $1.36B | 0.49% |
| EQLS | -7.50% | $8.94M | 1% |
| KMLM | -7.39% | $332.27M | 0.9% |
| HIGH | -7.00% | $298.33M | 0.52% |
| DBMF | -6.47% | $1.18B | 0.85% |
| WEAT | -6.34% | $122.96M | 0.28% |
| KRBN | -6.07% | $217.48M | 0.85% |
| CORN | -5.82% | $61.14M | 0.2% |
| FBY | -4.44% | $154.77M | 0.99% |
| KCCA | -4.27% | $123.70M | 0.87% |
| UNG | -3.49% | $854.11M | 1.06% |
| BIL | -1.76% | $34.60B | 0.1356% |
| TBIL | -1.52% | $4.51B | 0.15% |
| CSHI | -0.96% | $481.04M | 0.38% |
News
SeekingAlpha
Explore Baker Brothers' biotech-focused 13F portfolio, with notable stake increases in Incyte, Summit Therapeutics, and other small-cap firms. Read more here.
Yahoo
The U.S. stock market recently experienced a stumble, particularly in technology shares, as investors assessed earnings reports and economic data amidst fluctuating interest rates and inflation expectations. In such a climate, the appeal of penny stocks remains significant for those seeking affordable entry points with potential growth prospects. While the term "penny stocks" may seem outdated, these typically smaller or newer companies can offer unique opportunities when supported by strong...
Yahoo
CONCORD, Calif., November 13, 2024--Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences.
Yahoo
Cerus ( NASDAQ:CERS ) Third Quarter 2024 Results Key Financial Results Revenue: US$46.0m (up 16% from 3Q 2023). Net...
Yahoo
Q3 2024 Cerus Corp Earnings Call
Yahoo
Cerus Corp (CERS) reports a robust 16% increase in product revenue and raises full-year guidance, while navigating supply chain issues and regulatory hurdles.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.